New research led by investigators at Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary ...
Jul 15, 2021
0
13
New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to ...
Jul 14, 2021
0
1
St. Jude Children's Research Hospital scientists and collaborators in Sweden and Japan are reporting that the enzyme NUDT15 plays a role in how patients respond to antiviral therapy with the common drugs ganciclovir and acyclovir. ...
Jul 8, 2021
0
11
(HealthDay)—COVID-19 vaccinations may not offer as much protection to people with compromised immune systems, but just how much appears to be driven by the type of underlying condition, new research suggests.
Jul 7, 2021
0
1
(HealthDay)—Catheter ablation significantly improved major clinical outcomes compared with drug therapy among racial or ethnic minorities with atrial fibrillation (AF) enrolled in the CABANA trial, according to a study ...
Jul 7, 2021
0
1
The history of psychology is littered with unfortunate examples of treatments that caused more harm than benefit to patients. For instance, in the mid-20th century lobotomies were a common practice to treat mental illness, ...
Jul 1, 2021
0
6
Finding treatments for advanced multiple sclerosis (MS) has been difficult. But new research may help neurologists identify which drugs are best for people with the advanced form of MS called secondary progressive MS. The ...
Jun 30, 2021
0
3
Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma. Their findings were published on Friday, June 24, in The ...
Jun 26, 2021
0
22
Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that 'reboots' a treatment for some people with blood cancer whose cancer starts to come back.
Jun 25, 2021
0
0
COVID-19 therapies made from antibodies often are given to patients who are at high risk of severe illness and hospitalization. However, there have been nagging questions about whether such antibody therapies retain their ...
Jun 21, 2021
0
14
